Merck KGaA bets on cancer drugs to revitalise German firm
October 12, 2015 at 05:47 AM EDT
TEL AVIV, Oct 12 (Reuters) - Merck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, multiple sclerosis treatment Rebif.